FinancialsSector SheetSearch by SectorFilterXFor help & enquiries: 1-888-99-ADVFN (toll free)
Immuno. Sys
   

Immunodiagnostic Systems Company Financial Information

 Company name: Immuno. Sys
 EPIC: IDH Trading Currency: GBX
 Market Sector: AS50 ISIN: GB00B01YZ052
 Market Segment: AMSM Share Type: DE
 WWW Address:  Description: ORD 2P
 Industry Sector: HEALTH CARE EQUIPMENT & SERVICES
 Price Price Change [%] Bid Ask Open High Low Volume
 562.50 mages.advfn.com/imagesnew/2/us/dot 0.0 [0.00] 550.00 575.00 - - - 23,879
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 148.73 26.44 0.57 19.43 1.65 28.95 0.29 585.00 - -

Immunodiagnostic Systems Key Figures

(at previous day's close)
Market Cap.148.73m
Shares In Issue26.44m
Prev. Close562.50
PE Ratio28.95 
Dividend Yield0.29%
EPS - basic19.43p
Dividend PS1.65p
Dividend Cover11.78 
Cash Flow PS20.08p
Return On Equity (ROE)9.50%
Operating Margin19.17%
PEG Factor0.46 
EPS Growth Rate62.87%
Dividends PS Growth Rate32.00%
Net Debt24.95m
Gross Gearing36.70%
Quick Assets13.61m
Net Working Capital9.23m
Intangibles / Fixed Assets93.15%
Turnover PS94.31p
Pre-Tax Profit PS18.08p
Retained Profit PS16.87p
Cash PS16.85p
Net Cash PS-21.44p
Net Tangible Asset Value PS *-22.25p
Net Asset Value PS191.80p
Spread25.00 (4.35%) 

Immunodiagnostic Systems Balance Sheet

LSE:IDH:Liabilities+EQLSE:IDH:Assets

Immunodiagnostic Systems Share Price

Sample Period HighLow
1 week585.00-
4 weeks585.00-
12 weeks585.00-
1 year585.00-

Immunodiagnostic Systems Share Price (5 years)

Immunodiagnostic Systems Historic Returns

Giorni da oggi OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week520.0042.508.17542.500.03-555.64
4 weeks535.0027.505.14517.000.03-512.48
12 weeks352.00210.5059.80454.240.05-469.91
26 weeks228.00334.50146.71370.100.05-384.22
1 year203.00359.50177.09269.170.04-307.08
3 years213.50349.00163.47248.560.03-269.78
5 years55.00507.50922.73192.800.02-236.71

Immunodiagnostic Systems Key Management Ratios

Immunodiagnostic Systems Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio88.89 
PE Ratio28.95 
Tobin's Q Ratio 3.43 
Tobin's Q Ratio (excl. intangibles)10.30 
Dividend Yield0.29%
Market-to-Book Ratio2.93 
Price-to-Pre-Tax Profit PS31.11 
Price-to-Retained Profit PS33.35 
Price-to-Cash Flow PS28.01 
Price-to-Sales PS5.96 
Price-to-Net Tangible Asset Value PS-25.25 
Price-to-Cash PS33.38 
Net Working Capital PS34.90 
Price Pct to Working Capital PS16.12%
Earnings Yield3.45%
Average PE14.81 
Years in average4 
PE to PE average195.50%

Immunodiagnostic Systems Financial Ratios

(Leverage Ratios)
Debt Ratio27.55%
Debt-to-Equity Ratio0.38 
Debt-to-Equity Ratio (excl. Intgbl)-3.27 
Debt-to-Equity Market Value0.13 
Net Gearing31.14%
Net Gearing (excl. Intangibles)106.10%
Gross Gearing36.70%
Gross Gearing (excl. Intangibles)125.05%
Gearing Under 1 Year12.64%
Gearing Under 1 Year (excl. Intgbl)43.05%
Assets/Equity1.58 
Cash/Equity8.79 
(Liquidity Ratios)
Net Working Capital to Total Assets11.52%
Current Ratio1.91 
Quick Ratio (Acid Test)1.34 
Liquidity Ratio0.44 
Cash & Equiv/Current Assets23.03%
(Solvency Ratios)
Enterprise Value163.55m
CFO/Sales0.21 
CFO/Attributable Profit1.10 
CFO/Assets0.07 
CFO/Debt0.18 
Total Debt/Equity Market Value0.20 
Total Debt/Sales1.18 
Total Debt/Pre-Tax Profit6.15 
Total Debt29.41m
Total Debt/Net Current Assets3.19%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth41.42%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs- 
Beta (60-Mnth)Beta (36-Mnth)
0.57230.4468
Alpha (60-Mnth)Alpha (36-Mnth)
0.04990.0398

Immunodiagnostic Systems Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)6.83%
Return On Assets (ROA)11.13%
Net Profit Margin19.33%
Assets Turnover0.58 
Return On Equity (ROE)9.50%
Return On Investment (ROI)12.94%
Dividend Payout Ratio8.49%
Plowback Ratio91.51%
Growth from Plowback Ratio15.99%
Net Income Of Revenues17.88%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.90 
Fixed Assets Turnover0.79 
Current Assets Turnover2.14 
Net Working Capital Turnover- 
Inventory Turnover7.50 
(Other Operating Ratios)
Total Assets-to-Sales1.74 
Debtors-to-Sales22.59%
Debt Collection Period82.45Days

Immunodiagnostic Systems Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
22 Jun 2009FinalGBP1.6503/31/200803/31/200907/22/200907/24/200908/21/20091.65
16 Jul 2008FinalGBP1.5003/31/200703/31/200808/20/200808/22/200809/12/20081.50
16 Jul 2007FinalGBP1.2503/31/200603/31/200708/22/200708/24/200709/26/20071.25
05 Jul 2006FinalGBP1.0003/31/200503/31/200608/23/200608/25/200609/25/20061.00
-FinalGBP-03/31/200403/31/2005----

Immunodiagnostic Systems Fundamentals

 31 Mar 2005 (GBP)31 Mar 2006 (GBP)31 Mar 2007 (GBP)31 Mar 2009 (GBP)
turnover5.43100.00%8.13100.00%9.92100.00%24.94100.00%m
pre tax profit0.213.91%1.1714.44%2.1922.06%4.7819.17%m
attributable profit0.213.91%0.9211.27%1.5916.05%4.8219.33%m
retained profit0.213.91%0.9211.27%1.5916.05%4.4617.88%m
eps - basic6.44 6.87 11.93 19.43 
eps - diluted6.44 6.87 10.92 18.57 
dividends per share- 1.00 1.25 1.65 

Immunodiagnostic Systems Balance Sheet

 31 Mar 2005 (GBP)31 Mar 2006 (GBP)31 Mar 2007 (GBP)31 Mar 2009 (GBP)
LSE:IDH:Liabilities+EQLSE:IDH:AssetsLSE:IDH:Liabilities+EQLSE:IDH:AssetsLSE:IDH:Liabilities+EQLSE:IDH:AssetsLSE:IDH:Liabilities+EQLSE:IDH:Assets
 31 Mar 2005 (GBP)31 Mar 2006 (GBP)31 Mar 2007 (GBP)31 Mar 2009 (GBP)
ASSETS
fixed assets fixed assets0.6014.49%0.7514.65%1.3921.38%4.165.19%m
intangibles intangibles1.0725.58%1.0921.47%1.1417.45%56.6070.65%m
fixed investments fixed investments0.020.37%0.000.03%0.000.03%0.000.00%m
current assets - other current assets - other--%--%--%--%m
stocks stocks0.7618.31%0.8115.80%0.9114.04%5.747.16%m
debtors debtors1.2730.52%1.5630.67%2.1132.36%9.1611.43%m
cash & securities cash & securities0.4510.73%0.8917.37%0.9614.74%4.465.56%m
TOTAL4.16100%5.09100%6.51100%80.12100%m
LIABILITIES
creditors - short creditors - short1.5136.22%1.6632.65%1.9930.55%10.1212.64%m
creditors - long creditors - long0.9021.50%0.5611.06%0.091.37%19.2824.07%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL2.4057.72%2.2343.71%2.0831.92%29.4136.70%m
EQUITY
ord cap, reserves ord cap, reserves1.7642.28%2.8756.29%4.4368.08%50.7263.31%m
prefs, minorities prefs, minorities--%--%--%-0.01-0.01%m
TOTAL1.7642.28%2.8756.29%4.4368.08%50.7163.30%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Immunodiagnostic Systems Cash Flow Statement

31 Mar 2005 (GBP)31 Mar 2006 (GBP)31 Mar 2007 (GBP)31 Mar 2009 (GBP)
Operating CF-0.251.22-5.31m
Pre-Financing CF-1.180.73-0.13m
Retained CF0.360.44-1.48m

Immunodiagnostic Systems Brokers

NameActivityTypeMnemonicCode
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Kbc Peel Hunt LdMarket Maker(MMF)Broker/DealerKBCKBCSGB21BIC
Teather & Greenwood LdMarket Maker(MMF)Broker/DealerTEAMTGREGB21
Winterflood Secs LdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC



LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2009 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
34 site:2us lse idh091122 00:01 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 )